Table 4 Participants with neuropathy symptoms frequency in both groups at the baseline and 4, 8, and 12Â weeks
Outcome measure | Baseline | 4Â weeks | 8Â weeks | 12Â weeks | |
|---|---|---|---|---|---|
Magnet (n = 32) No. (%) | Burning | 30 (93.8) | 25 (78.1) | 17 (53.1) | 10 (31.3) |
Numbness | 27 (84.4) | 19 (59.4) | 7 (21.9) | 2 (6.3) | |
Paresthesia | 30 (93.8) | 23 (71.9) | 10 (31.3) | 4 (12.5) | |
Feeling of weakness (fatigue, exhaustion) | 24 (75) | 11 (34.4) | 4 (12.5) | 0 (0) | |
Cramps | 27 (84.4) | 12 (37.5) | 4 (12.5) | 0 (0) | |
Pain | 32 (100) | 29 (90.6) | 27 (84.4) | 12 (37.5) | |
Awakened from sleep | 18 (56.3) | 6 (18.8) | 2 (6.3) | 0 (0) | |
Sham (n = 32) No. (%) | Burning | 31 (96.9) | 31 (96.9) | 31 (96.9) | 31 (96.9) |
Numbness | 27 (84.4) | 27 (84.4) | 26 (81.3) | 26 (81.3) | |
Paresthesia | 30 (93.8) | 30 (93.8) | 30 (93.8) | 30 (93.8) | |
Feeling of weakness (fatigue, exhaustion) | 26 (81.3) | 25 (78.1) | 24 (75) | 24 (75) | |
Cramps | 19 (59.4) | 19 (59.4) | 19 (59.4) | 19 (59.4) | |
Pain | 32 (100) | 32 (100) | 32 (100) | 32 (100) | |
Awakened from sleep | 23 (71.9) | 23 (71.9) | 21 (65.6) | 17 (53.1) | |
P value | |||||
|---|---|---|---|---|---|
Burning | 0.053 |  < 0.001a |  < 0.001a | ||
Numbness | 0.050 |  < 0.001a |  < 0.001a | ||
Paresthesia | 0.04a |  < 0.001a |  < 0.001a | ||
Feeling of weakness (fatigue, exhaustion) | 0.001a |  < 0.001a |  < 0.001a | ||
Cramps | 0.13 |  < 0.001a |  < 0.001a | ||
Pain | 0.23 | 0.053 |  < 0.001a | ||
Awakened from sleep |  < 0.001a |  < 0.001a |  < 0.001a | ||